Isotyping paranodal antibodies in inflammatory neuropathies
One step closer to precision care
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published July 24, 2020.
Author Disclosures
- Cinta Lleixà, BSc and
- Luis Querol, MD, PhD
- Cinta Lleixà, BSc and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Luis Querol, MD, PhD
Commercial entity: Sanofi-Genzyme, CSL Bering, Grifols, Novartis, UCB Pharma, Johnson and Johnson, Alexion, Annexon
NONE
Commercial: CSL Behring, Novartis, Roche and Biogen, travel grant
Editorial Board Member of the European Journal of Neurology
NONE
NONE
NONE
NONE
Commercial: CSL Behring, Roche, Sanofi, Grifols, Merck, Novartis
NONE
NONE
Grifols
(1) Fondo de Investigaciones Sanitarias, PI19/01407 (2) SLT006/17/00131 of the Pla estratègic de Recerca i Innovació en Salut (PERIS), Departament de Salut, Generalitat de Catalunya (3) ACCI 2019-30 CIBERER
NONE
GBS-CIDP Foundation International
NONE
NONE
NONE
NONE
NONE
NONE
- From the Neuromuscular Diseases Unit (C.L., L.Q.), Neurology Department, Hospital de la Santa Creu I Sant Pau, Barcelona; and Centro para la Investigación Biomédica en Red en Enfermedades Raras (C.L., L.Q.), CIBERER, Madrid, Spain.
- Correspondence
Dr. Querol lquerol{at}santpau.cat
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDPClinical relevance of IgG isotypeAndrea Cortese, Raffaella Lombardi, Chiara Briani et al.Neurology: Neuroimmunology & Neuroinflammation, November 21, 2019 -
Article
Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathyLuise Appeltshauser, Anna-Michelle Brunder, Annika Heinius et al.Neurology: Neuroimmunology & Neuroinflammation, July 24, 2020 -
Article
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgLuis Querol, Gisela Nogales-Gadea, Ricardo Rojas-Garcia et al.Neurology, February 12, 2014 -
Article
Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathyHelena Stengel, Atay Vural, Anna-Michelle Brunder et al.Neurology: Neuroimmunology & Neuroinflammation, August 16, 2019